SHIB Price Prediction: The Big Question Answered, Can Shiba Inu Ever Hit $0.01?
Sangamo Therapeutics’ stock falls the most in 16 years after Pfizer ends hemophilia pact
Sangamo Therapeutics’ stock falls the most in 16 years after Pfizer ends hemophilia pact
Pfizer move means Sangamo won’t receive an expected payout in the first quarter, creating a cash overhang.
